会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明公开
    • RESIDENCE STRUCTURES AND RELATED METHODS
    • WOHNUNGSSTRUKTUREN UNDZUGEHÖRIGEVERFAHREN
    • EP3155024A1
    • 2017-04-19
    • EP15806017.8
    • 2015-06-11
    • Massachusetts Institute Of TechnologyThe Brigham and Women's Hospital, Inc.
    • BELLINGER, AndrewZHANG, ShiyiTRAVERSO, Carlo, GiovanniLANGER, Robert, S.MO, StacyGRANT, TylerJAFARI, MousaGLETTIG, Dean LiangDICICCIO, AngelaWOOD, Lowell L. Jr.ECKHOFF, Philip A.
    • C08F8/00C08G63/682
    • Described are gastric residence structures that include an active substance. The gastric residence structures may include one or more arms that include a loadable polymeric component, an elastic polymeric component, and a separate linker component. The linker may connect the one or more arms with the elastic polymeric component. The gastric residence structures may be configured to be folded and physically constrained during administration and may be configured to assume an open retention shape upon removal of a constraint. The change between the folded shape and the open retention shape may be mediated by the elastic polymeric component that undergoes elastic deformation when the residence structure is in the folded shape and recoils when the gastric residence structure assumes the open retention shape.
    • 通常提供住宅结构,系统和相关方法。 某些实施方案包括将住院结构施用(例如,口服)给对象(例如,患者),使得住宿结构保持在受试者内部某一时间(例如,至少约24小时) 在被释放之前。 在一些情况下,住院结构可以是胃停留结构。 在一些实施方案中,本文所述的结构和系统包括一种或多种配置用于在酸性环境中高水平的活性物质(例如治疗剂)负载,高活性物质和/或结构稳定性,在内部的机械柔性和强度 孔(例如,胃腔),容易通过胃肠道直到输送到期望的内部孔口(例如胃腔),和/或在生理环境(例如,肠环境)中快速溶解/降解)和/或 对化学刺激剂的反应(例如,摄入引起快速溶解/降解的溶液)。 在某些实施方案中,该结构具有模块化设计,将配置用于控制释放治疗剂,诊断和/或增强剂的材料与胃停留所必需的结构材料组合,但被配置用于控制和/或可调节的降解/溶解以确定 保留形状完整性丧失并且结构从胃腔排出的时间。 例如,在某些实施方案中,宿主结构包括第一弹性组分,被配置成释放活性物质(例如治疗剂)的第二组分和任选的连接体。 在一些这样的实施方案中,接头可以被配置为降解,使得停留结构在预定量的时间之后分裂并且从受试者内部的位置释放。
    • 10. 发明申请
    • TEMPERATURE-CONTROLLED MEDICINAL STORAGE DEVICES
    • 温度控制药物储存装置
    • WO2016022681A1
    • 2016-02-11
    • PCT/US2015/043808
    • 2015-08-05
    • TOKITAE LLC
    • CHOU, Fong-LiECKHOFF, Philip A.FOWLER, Lawrence MorganLARUSSON, FridrikLIU, ShiengPETERSON, Nels R.TEGREENE, Clarence T.WOOD, Lowell L., Jr.
    • A61J1/14A61J1/00
    • F25D16/00A61J1/00F25B25/02F25D2400/02
    • In some embodiments, a medicinal storage container includes: a desiccant unit including external walls forming a gas-impermeable barrier around an interior desiccant region and including an aperture; a heating element; a controller operably attached to the heating element; a cooling unit; a compressor system including at least one evaporator coil unit, the compressor operably connected to the controller; a vapor conduit, the vapor conduit attached to a the desiccant unit at a first end, the vapor conduit attached to the evaporative cooling unit at a second end, the vapor conduit forming an internal, gas-impermeable passageway between the desiccant unit and the cooling unit; a vapor control unit attached to the vapor conduit and operably attached to the controller; and a medicinal storage unit including external walls encircling a medicinal storage region including a temperature sensor operably connected to the controller.
    • 在一些实施方案中,药物储存容器包括:干燥剂单元,其包括在内部干燥剂区域周围形成气体不可渗透屏障并包括孔的外壁; 加热元件; 可操作地连接到加热元件的控制器; 冷却单元; 压缩机系统,包括至少一个蒸发器盘管单元,所述压缩机可操作地连接到所述控制器; 蒸汽导管,在第一端处附接到干燥剂单元的蒸汽导管,在第二端处附接到蒸发冷却单元的蒸汽导管,蒸汽导管在干燥剂单元和冷却剂之间形成内部不透气通道 单元; 蒸汽控制单元,其连接到蒸汽管道并可操作地附接到控制器; 以及医疗储存单元​​,其包括围绕包括可操作地连接到所述控制器的温度传感器的医疗储存区域的外壁。